Apatinib in the Treatment of Metastatic Colorectal Cancer
Status:
Unknown status
Trial end date:
2019-12-31
Target enrollment:
Participant gender:
Summary
This is an Exploratory Clinical Trial Study on Apatinib in the Treatment of Metastatic
Colorectal Cancer Who Have Progressed after Standard Second Line Therapy.